Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Neoplasm Metastasis × durvalumab × Sarcoma × Clear all

Phase

Status

Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 7 Gastrointestinal 6 Tumor-Agnostic 5 Thoracic 5 Head & Neck 3 Dermatologic 3 Genitourinary 2 Sarcoma 1 Plasma cell 1 Other hematologic neoplasm 1 Myeloid 1 Lymphoid 1 Gynecologic 1 Classical hematology 1

Conditions

Sarcoma 6 Melanoma 3 Hemangiosarcoma 3 Breast Neoplasms 3 Prostatic Neoplasms 2 Osteosarcoma 2 Neoplasms 2 Vascular Neoplasms 1 Uterine Cervical Neoplasms 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Thyroid Neoplasms 1 Testicular Neoplasms 1 Tertiary Lymphoid Structures 1 Squamous Cell Carcinoma of Head and Neck 1 Sarcoma, Synovial 1 Pathologic Complete Response 1 Pancreatic Neoplasms 1 Ovarian Neoplasms 1 Neoplasm Metastasis 1 Lymphoma, T-Cell, Cutaneous 1 Liposarcoma 1 Leiomyosarcoma 1 Kidney Neoplasms 1 Histiocytoma, Malignant Fibrous 1 Hemangioendothelioma, Epithelioid 1 Head and Neck Neoplasms 1 Glioma 1 Glioblastoma 1 Endometrial Neoplasms 1

Interventions

pembrolizumab 8 Ibandronic Acid 8 Gemcitabine 8 Doxorubicin 8 Cyclophosphamide 8 Specimen Handling 7 pazopanib 6 Biopsy 6 Radiosurgery 5 Nivolumab 5 Magnetic Resonance Spectroscopy 5 Imatinib Mesylate 5 Bevacizumab 5 regorafenib 4 Zoledronic Acid 4 Irinotecan 4 Docetaxel 4 Radiation 3 Ifosfamide 3 Cryosurgery 3 Carboplatin 3 trastuzumab deruxtecan 2 trametinib 2 temsirolimus 2 sargramostim 2 olaparib 2 masitinib 2 ganitumab 2 futibatinib 2 conatumumab 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03784014 2025-12-11

MULTISARC

Institut National de la Santé Et de la Recherche Médicale, France

Phase 3 Active not recruiting

Neoplasm Metastasis, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡